🔻 疫苗批號揭示了一種模式, 這並非偶然。
2026年6月28日 上午7:42。研究人員將12000個疫苗批號與疫苗不良事件通報系統（VAERS）中的不良事件報告進行了交叉比對。他們的發現是：特定批次的疫苗不良事件發生率顯著高於其他批次。
這不是陰謀論。這是數據。
數據顯示：
這種相關性確實存在。這一點已有記錄。
批號以20A-20F結尾：不良事件通報最少
批號以21K-21X結束：不良事件發生率較高（心肌炎、血栓、住院）
批號以22R-22Z結尾：不良事件發生率最高
這種模式是真實存在的。問題是：為什麼？
隱密調查
我從製藥業的聯絡人那裡得知：FDA（美國食品藥物管理局）了解這種模式。
他們幾個月前就知道了。
但他們沒有說的是：這些批次的藥品並非隨機分配。
高不良反應批次的藥品不成比例地分配到：
▪️ 軍事基地
▪️ 急救機構
▪️ 農村社區
▪️ 特定人群聚集區
低不良反應批次的藥品則分配給了：
▪️ 政府官員
▪️ 媒體人士
▪️ 製藥公司高階主管
▪️ 他們的家人
真正的問題
這是生產過程中的不一致？還是人為的？
我從製藥供應鏈的聯絡人那裡得知：出現三種截然不同的批次絕非偶然。
要么：
1. 品質控制失敗（可能性不大）
2. 分銷是故意的（數據顯示如此）
時間軸
- 2021-2022：批次分銷
- 2023-2024年：不良事件模式出現
- 2025年：FDA 知曉
- 2026年：資料分析完成
- 現在：研究人員發布研究結果
掩蓋真相
我從監理機構內部人士獲悉：多家期刊拒絕同儕審查。並非因為方法論有缺陷，而是因為研究結果「涉及政治敏感資訊」。
研究人員直接發布了研究結果。數據現已公開。
12,000 個批號。每個分銷點。每起不良事件關聯。每家醫院。每個州。
FDA 無法掩蓋真相。數據已在網路中傳播。
這就是他們恐慌的原因。
接下來會發生什麼
國會將展開調查。分銷模式過於具體，不容忽視。
如果是隨機的生產差異，那麼分發也應該是隨機的。但事實並非如此。
如果是人為造成的差異，那就是另一個話題了。
無論如何，數據都要求我們給出答案。
疫苗批號模式 0628
不良事件相關
分發存疑
批號是證據。分發模式是規律。不良事件是結果。
你認識的人可能接種的疫苗配方與被告知的不符。
🔻 VACCINE LOT NUMBERS JUST EXPOSED A PATTERN. AND IT'S NOT RANDOM.
June 28, 2026. 07:42 AM. Researchers cross-referenced 12,000 vaccine lot numbers with VAERS adverse event reports. What they found: specific batches had significantly higher adverse event correlations than others.
This isn't conspiracy. This is data.
WHAT THE DATA SHOWS
The correlation exists. That's documented.
Lot numbers ending in 20A-20F: minimal adverse events reported
Lot numbers ending in 21K-21X: elevated adverse events (myocarditis, blood clots, hospitalizations)
Lot numbers ending in 22R-22Z: highest adverse event concentrations
The pattern is real. The question is: WHY?
THE HIDDEN INVESTIGATION
I've been told by pharmaceutical industry contacts: The FDA knows about this pattern.
They've known for months.
But here's what they're NOT saying: The distribution of these lots wasn't random.
The high-adverse-event batches were disproportionately distributed to:
▪️ Military bases
▪️ First responder facilities
▪️ Rural communities
▪️ Specific demographic clusters
The low-adverse-event batches went to:
▪️ Government officials
▪️ Media figures
▪️ Pharmaceutical executives
▪️ Their families
THE REAL QUESTION
Was this manufacturing inconsistency? Or deliberate?
I've been told by pharmaceutical supply chain contacts: You don't get THREE DISTINCT TIERS by accident.
Either:
1. Quality control failed (unlikely)
2. Distribution was intentional (data suggests this)
THE TIMELINE
- 2021-2022: Lots distributed
- 2023-2024: Adverse event patterns emerged
- 2025: FDA became aware
- 2026: Data analysis complete
- NOW: Researchers releasing findings
THE COVER-UP
I've been told by contacts inside regulatory agencies: Multiple journals rejected peer review. Not because methodology was flawed. Because findings were "politically sensitive."
The researchers released it directly. The data is now public.
12,000 lot numbers. Every distribution point. Every adverse event correlation. Every hospital. Every state.
The FDA cannot memory-hole this. Data is distributed across networks.
This is why they're panicking.
WHAT HAPPENS NEXT
Congress will investigate. The distribution pattern is too specific to ignore.
If random manufacturing variance, distribution would be random. It wasn't.
If intentional, that's a different conversation.
Either way, the data demands answers.
VACCINE-LOT-PATTERN-0628
ADVERSE-EVENTS-CORRELATED
DISTRIBUTION-QUESTIONED
The lot numbers are the evidence. The distribution is the pattern. The adverse events are the outcome.
Someone you know got a different formula than they were told.
